This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Consejo Superior De Investigaciones Cientificas. Active years: 2013-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2015
Title: Antonio Morreale De Leon: Innovator in Immunosuppressive Compounds
Introduction
Antonio Morreale De Leon is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of medicinal chemistry, particularly in the development of immunosuppressive agents. With a total of 2 patents, his work focuses on innovative compounds that have the potential to impact therapeutic practices.
Latest Patents
Antonio's latest patents include groundbreaking work on chromene derivatives. The first patent details derivatives of chromene of formula I, where the meanings for the various substituents are specified in the description. These compounds are particularly useful as inhibitors of TCR-Nck interaction in T lymphocytes. His second patent relates to an immunosuppressor based on the blockage of TCR-Nck interaction. This invention describes a compound of structural formula (I) and its derivatives for use as medicinal drugs, primarily as immunosuppressive agents.
Career Highlights
Antonio Morreale De Leon is affiliated with the Consejo Superior de Investigaciones Científicas, a prominent research institution in Spain. His work has garnered attention for its potential applications in immunology and therapeutic interventions.
Collaborations
Throughout his career, Antonio has collaborated with esteemed colleagues, including Balbino Jose Alarcon Sanchez and Aldo Jorge Borroto Revuelta. These collaborations have contributed to the advancement of his research and the development of innovative solutions in the field.
Conclusion
Antonio Morreale De Leon stands out as a significant figure in the realm of immunosuppressive compounds. His innovative patents and collaborations reflect his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile